Indegene Limited's board will meet on April 29, 2026, to approve audited financial results for Q4 and FY ending March 31, 2026.
The board will recommend a final dividend for FY2026, subject to shareholder approval at the AGM.
Allotment of shares under ESOP Scheme 2020 and RSU Scheme 2020 will be approved during the meeting.
The trading window closure began April 1, 2026, and will reopen 48 hours after results declaration.